As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to
be held on the 23rd of April 2025, at 12:00.
Please click on...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs
for cancer and infections, announces the publication of new sci...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs
for cancer and infections, announces the publication of new sci...
Hamlet BioPharma, the pharmaceutical company, specializing in the
development of drugs for cancer and infections, announces that Hamlet
BioPharma’s dr...
Som tidigare meddelats bjuder Hamlet BioPharma in till månatligt investerarmöte
onsdagen den 12 mars, 2025, klockan 12.00.
Klicka på länken nedan för ...
Vid extra bolagsstämma i Hamlet BioPharma AB (publ), org.nr 556568-8958, (”Hamlet
BioPharma” eller ”Bolaget”) idag den 11 mars 2025 fattades bland ann...
Med anledning av Pressmeddelanden och nyheter bjuder Hamlet BioPharma in till investerarmöte fredagen den 21 februari, 2025, klockan 12.00.
Bolaget k...
Aktieägarna i Hamlet BioPharma AB (publ) (”Hamlet BioPharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma tisdagen den ...
Hamlet BioPharma has appointed Elisabeth Parker, PhD to strengthen the business development expertise in the company. Dr. Parker has 25 years’ experi...
The Board of Hamlet BioPharma has today decided to appoint Catharina Svanborg as CEO. Catharina immediately assumes the CEO role and continues as a B...
Med anledning av bolagets kvartalsrapport 2 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 13 februari, 2...
Hamlet BioPharma AB, det innovativa läkemedelsbolaget, som utvecklar nya terapier mot cancer och infektioner, meddelar två viktiga händelser.
Den 6 f...
Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuab...
Hamlet BioPharma AB, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att företaget kommer att delta och...
Hamlet BioPharma AB (”Hamlet BioPharma” eller ”Bolaget”), ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddel...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...
Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 21 november 2024 fattades de beslut som beskrivs ned...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces its participation in the B...
Med anledning av bolagets kvartalsrapport 1 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff måndagen den 18 november, 20...
Hamlet BioPharma, ticker HAMLET B, the innovative pharmaceutical company, which develops new therapies against cancer and infections, is pleased to in...
Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till årsstämma torsdagen den 21 november 2024 klockan 15:00 på High C...
Hamlet BioPharma, det innovativa läkemedelsbolaget, som utvecklar nya terapier mot cancer och infektioner, meddelar att bolaget nu har tre framgångsri...
Hamlet BioPharma fortsätter sin serie av livesända digitala investerarmöten, där vi presentera pågående arbete inom bolagets breda projektportfölj.
Me...
Hamlet BioPharma fortsätter nu serien av livesända digitala investerarmöten, där medarbetare presenterar sitt pågående arbete i bolagets breda projekt...
Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a leading international newspaper. The article hig...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces that Hamlet BioPharma’s dr...
Med anledning bolagets bokslutskommuniké för 2023/2024, bjuder Hamlet BioPharma in till en livesänd digital pressträff onsdagen den 28 augusti klockan...
Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportu...
Hamlet BioPharma was selected by Media Planet, the media agency for The Guardian, to be featured in the Health Awareness campaign, BLADDER AND BOWEL H...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Gl...
Med anledning bolagets delårsrapport för tredje kvartalet, bjuder Hamlet BioPharma in till en livesänd digital investerarträff fredagen den 24 maj klo...
Hamlet BioPharma announced on January 25 that clinical data showed a strong immune response with anti-tumor potential in Alpha1H-treated patients with...
Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced t...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce its participati...
DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN...
Med anledning av bolagets delårsrapport bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 22 februari klockan 12.00. På pr...
